Researchers at more than 40 Canadian hospitals and several universities, including Jeannie Callum of U of T and Sunnybrook, seek to test whether blood plasma from recovered COVID-19 patients can be used as a treatment (photo by Nick Iwanyshyn)

U of T plays leading role in effort to develop COVID-19 treatment from recovered patients’ blood plasma

Posted on

Researchers at the University of Toronto are playing a leading role in a national effort to study the efficacy of using blood plasma from recovered COVID-19 patients to treat those who are sick with the disease.

The joint effort with researchers at more than 40 Canadian hospitals, the Université de Montréal, University of Ottawa, McMaster University and the University of British Columbia seeks to test whether it helps to transfuse plasma – the pale yellow liquid from whole blood that is rich in antibodies – from people who have recovered from COVID-19 to patients suffering from the illness….

https://www.utoronto.ca/news/u-t-plays-leading-role-effort-develop-covid-19-treatment-recovered-patients-blood-plasma

Read More Impact Stories

Posted on
McGill-developed device offers 100 per cent accuracy in as little as 10 minutes, and can be configured to detect a [...]
Posted on
This content is available in French only.
Posted on
The University of Toronto and Moderna, Inc. known for its mRNA-based COVID-19 vaccine plan to work together to develop new [...]